The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.

Rid, Annette; Lipsitch, Marc; Miller, Franklin G

Rid, Annette; Lipsitch, Marc; Miller, Franklin G.

Rid A; Department of Bioethics, The Clinical Center, National Institutes of Health, Bethesda, Maryland.
Lipsitch M; Center for Communicable Disease Dynamics, Department of Epidemiology, Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Miller FG; Weill Cornell Medical College, New York, New York.

JAMA ; 325(3): 219-220, 2021 01 19.

Article in English | MEDLINE | ID: covidwho-1086204

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; Clinical Trials as Topic/ethics; Placebos/administration & dosage; SARS-CoV-2/immunology; Vaccination/ethics; COVID-19 Vaccines/supply & distribution; Health Equity/ethics; Humans; Patient Selection/ethics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Placebos / Clinical Trials as Topic / Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: JAMA Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google